Philadelphia, PA, 20 August, 2010 – The hormone oxytocin has come under intensive study in light of emerging evidence that its release contributes to the social bonding that occurs between lovers, friends, and colleagues. Oxytocin also plays an important role in birth and maternal behavior, but until now, research had never addressed the involvement of oxytocin in the transition to fatherhood.
A fascinating new paper by Gordon and colleagues reports the first longitudinal data on oxytocin levels during the initiation of parenting in humans. They evaluated 160 first-time parents (80 couples) twice after the birth of their first child, at 6 weeks and 6 months, by measuring each parents’ oxytocin levels and monitoring and coding their parenting behavior.
Three important findings emerged. At both time-points, fathers’ oxytocin levels were not different from levels observed in mothers. Thus, although oxytocin release is stimulated by birth and lactation in mothers, it appears that other aspects of parenthood serve to stimulate oxytocin release in fathers.
Corresponding author Dr. Ruth Feldman noted that this finding “emphasizes the importance of providing opportunities for father-infant interactions immediately after childbirth in order to trigger the neuro-hormonal system that underlies bond formation in humans.”
The neuroscientists also found a relationship between oxytocin levels in husbands and wives. Since oxytocin levels are highly stable within individuals, this finding suggests that some mechanisms, perhaps social or hormonal factors, regulate oxytocin levels in an interactive way within couples.
Finally, the findings revealed that oxytocin levels were associated with parent-specific styles of interaction. Oxytocin was higher in mothers who provided more affectionate parenting, such as more gazing at the infant, expression of positive affect, and affectionate touch. In fathers, oxytocin was increased with more stimulatory contact, encouragement of exploration, and direction of infant attention to objects.
“It is very interesting that elevations in the same hormone were associated with different types of parenting behaviors in mothers and fathers even though the levels of oxytocin within couples were somewhat correlated. These differences may reflect the impact of culture-specific role expectations, but they also may be indicative of distinct circuit effects of oxytocin in the male and female brain,” commented Dr. John Krystal, Editor of Biological Psychiatry.
These important findings may now provide a foundation for studies of disturbances in oxytocin function in high risk parenting.
Notes to Editors:
The article is “Oxytocin and the Development of Parenting in Humans” by Ilanit Gordon, Orna Zagoory-Sharon, James F. Leckman, and Ruth Feldman. Gordon, Zagoory-Sharon, and Feldman are affiliated with Bar-Ilan University, Ramat-Gan, Israel. Leckman and Feldman are affiliated with Yale University, New Haven, Connecticut. The study was supported by the US-Israel Bi-National Science Foundation. The article appears in Biological Psychiatry, Volume 68, Issue 4 (August 15, 2010), published by Elsevier.
The authors’ disclosures of financial and conflicts of interests are available in the article.
John H. Krystal, M.D. is Chairman of the Department of Psychiatry at the Yale University School of Medicine and a research psychiatrist at the VA Connecticut Healthcare System. His disclosures of financial and conflicts of interests are available at http://journals.elsevierhealth.com/webfiles/images/journals/bps/Biological-Psychiatry-Editorial-Disclosures-7-22-10.pdf.
Full text of the article mentioned above is available upon request. Contact Maureen Hunter at [email protected] to obtain a copy or to schedule an interview.
About Biological Psychiatry
This international rapid-publication journal is the official journal of the Society of Biological Psychiatry. It covers a broad range of topics in psychiatric neuroscience and therapeutics. Both basic and clinical contributions are encouraged from all disciplines and research areas relevant to the pathophysiology and treatment of major neuropsychiatric disorders. Full-length and Brief Reports of novel results, Commentaries, Case Studies of unusual significance, and Correspondence and Comments judged to be of high impact to the field are published, particularly those addressing genetic and environmental risk factors, neural circuitry and neurochemistry, and important new therapeutic approaches. Concise Reviews and Editorials that focus on topics of current research and interest are also published rapidly.
Biological Psychiatry (www.sobp.org/journal) is ranked 4th out of 117 Psychiatry titles and 13th out of 230 Neurosciences titles in the 2009 ISI Journal Citations Reports® published by Thomson Reuters. The 2009 Impact Factor score for Biological Psychiatry has increased to 8.926.
About Elsevier
Elsevier is a world-leading publisher of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including the Lancet (www.thelancet.com) and Cell (www.cell.com), and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier’s online solutions include ScienceDirect (www.sciencedirect.com), Scopus (www.scopus.com), Reaxys (www.reaxys.com), MD Consult (www.mdconsult.com) and Nursing Consult (www.nursingconsult.com), which enhance the productivity of science and health professionals, and the SciVal suite (www.scival.com) and MEDai’s Pinpoint Review (www.medai.com), which help research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier (www.elsevier.com) employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC (www.reedelsevier.com), a world-leading publisher and information provider. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
